Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Isurugi

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Hinyokika Kiyo. Acta Urologica Japonica|February 1, 1988
[Endocrine therapy of prostatic carcinoma with slow release (depot) formulation of the LH-RH analog ICI 118630 (Zoladex)]M Usami, T Kotake, M Matsuda, et al.
Endocrine Journal|October 1, 1996
Incomplete testicular feminization syndrome: studies on androgen receptor(AR) function, AR gene analysis, and aromatase activities at puberty and long-term observations of clinical and hormonal features from infancy to pubertyK Isurugi, F Hasegawa, N Shibahara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1986
[Phase I study of bestrabucil (KM 2210)]H Kamei, K Takenaka, T Goto, et al.
Japanese Journal of Clinical Oncology|December 1, 1988
A prospective, randomized controlled study on the treatment of stage C and stage D prostatic cancer with estracyt in combination with other chemotherapeutic agentsH Akaza, K Isurugi, Y Oishi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1985
[Clinical application of extracorporeal shock wave lithotripter]T Niijima, K Isurugi, T Umeda, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 1, 1992
[Hypothyroidism followed by interferon-alpha as adjuvant therapy of renal cell carcinoma: a case report]H Ueda, A Ishikawa, S Itoh, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 1, 1988
[Clinical experience with single and multiple subcutaneous administration of LHRH analog Buserelin (Hoe 766) in prostatic carcinoma: endocrinological study of optimum subcutaneous doses]T Niijima, K Isurugi, K Kawabe, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Hinyokika Kiyo. Acta Urologica Japonica|February 1, 1988
[Endocrine therapy of prostatic carcinoma with slow release (depot) formulation of the LH-RH analog ICI 118630 (Zoladex)]M Usami, T Kotake, M Matsuda, et al.
Endocrine Journal|October 1, 1996
Incomplete testicular feminization syndrome: studies on androgen receptor(AR) function, AR gene analysis, and aromatase activities at puberty and long-term observations of clinical and hormonal features from infancy to pubertyK Isurugi, F Hasegawa, N Shibahara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1986
[Phase I study of bestrabucil (KM 2210)]H Kamei, K Takenaka, T Goto, et al.
Japanese Journal of Clinical Oncology|December 1, 1988
A prospective, randomized controlled study on the treatment of stage C and stage D prostatic cancer with estracyt in combination with other chemotherapeutic agentsH Akaza, K Isurugi, Y Oishi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1985
[Clinical application of extracorporeal shock wave lithotripter]T Niijima, K Isurugi, T Umeda, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 1, 1992
[Hypothyroidism followed by interferon-alpha as adjuvant therapy of renal cell carcinoma: a case report]H Ueda, A Ishikawa, S Itoh, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 1, 1988
[Clinical experience with single and multiple subcutaneous administration of LHRH analog Buserelin (Hoe 766) in prostatic carcinoma: endocrinological study of optimum subcutaneous doses]T Niijima, K Isurugi, K Kawabe, et al.
Pageof 11